Initial MRI showed asymptomatic brain lesions in 14% of patients, increasing to 25% at 6 months

ASCO's CDK4/6 Inhibitor Dosing Knowledge (CDK) Study prioritizes patient advocacy and engagement to improve outcomes and quality of life for individuals with cancer.

Clare Cory was 59 years old and had been single almost her whole life. She thought her love story was over. Then everything changed.

Aneuploid epithelial cells are common in breast cancer^1,2; however, their presence in normal breast tissues is not well understood. To address this question, we applied single-cell DNA sequ...

Breast cancer is often thought of as a woman’s disease. But men can get breast cancer, too. Breast medical oncologist Sharon Giordano, M.D., shares insights about male breast cancer.

The phase 3 SONIA trial challenges the benefits of using cyclin-dependent kinase 4 and 6 inhibitors as a first-line compared with second-line treatment.

SABCS is the world's largest gathering of doctors, researchers and scientists sharing state-of-the-art information on experimental biology, etiology, prevention, diagnosis, and therapy for breast canc...